Better health is associated with a higher risk of heart disease.

Published Date: 17 Feb 2023

UK: More health is associated with more cardiovascular disease (CVD) and higher triglycerides...

Read Full News

Latest News

Predictors Identified for Super-Responder Status to Dupilumab in Atopic Dermatitis

Predictors Identified for Super-Responder Status to Dupilumab in Atopic Dermatitis

12 Months of Low-Level Laser Therapy at Home Improves Androgenetic Alopecia

12 Months of Low-Level Laser Therapy at Home Improves Androgenetic Alopecia

BEACON: Positive Results Announced for Briquilimab in Chronic Spontaneous Urticaria

BEACON: Positive Results Announced for Briquilimab in Chronic Spontaneous Urticaria

Family Quality of Life Burden in CSU Increased by Lack of Disease Control

Family Quality of Life Burden in CSU Increased by Lack of Disease Control

Upadacitinib Superior to 4 Other JAKi Monotherapies for Atopic Dermatitis

Upadacitinib Superior to 4 Other JAKi Monotherapies for Atopic Dermatitis

Q4 2025 Recap: Dermatology News and Updates

Q4 2025 Recap: Dermatology News and Updates

Todays Updates

7 Rheumatology Headlines You Missed in October 2025 Victoria Johnson

The rheumatology month in review emphasizes new data presented at the 2025 ACR Convergence.

ACR Convergence 2025 Recap: Late-Breaking Trials to Know Victoria Johnson

A compilation of 13 trials presented as late-breaking data at ACR Convergence 2025.

Unseen Symptoms: Cognitive Decline Reveals Quality-of-Life Impacts of SLE, with Carla Cuda, PhD Carla Marie Cuda, PhD

New research at ACR 2025 highlights the link between cognitive impairment and disease activity in SLE.

This Year in Medicine 2025: Recognizing Top Advances in Healthcare HCPLive Editorial Staff

Explore groundbreaking advancements in healthcare as 2025 concludes, featuring expert insights and dynamic multimedia.

5 Rheumatology Headlines You Missed in November 2025 Victoria Johnson

This rheumatology month in review emphasizes new data from the ACR Convergence.

Firsekibart Beats Colchicine as Gout Flare Prophylaxis When Initiating ULT Victoria Johnson

New data support firsekibart's efficacy over colchicine for preventing acute gout flares.

Lingdolinurad Demonstrates Dose-Dependent Serum Uric Acid Reductions Victoria Johnson

A new study reveals ligdolinurad effectively lowers uric acid levels in gout patients, showcasing promising safety and tolerability results.

Todays Updates

7 Rheumatology Headlines You Missed in October 2025 Victoria Johnson

The rheumatology month in review emphasizes new data presented at the 2025 ACR Convergence.

ACR Convergence 2025 Recap: Late-Breaking Trials to Know Victoria Johnson

A compilation of 13 trials presented as late-breaking data at ACR Convergence 2025.

Unseen Symptoms: Cognitive Decline Reveals Quality-of-Life Impacts of SLE, with Carla Cuda, PhD Carla Marie Cuda, PhD

New research at ACR 2025 highlights the link between cognitive impairment and disease activity in SLE.

This Year in Medicine 2025: Recognizing Top Advances in Healthcare HCPLive Editorial Staff

Explore groundbreaking advancements in healthcare as 2025 concludes, featuring expert insights and dynamic multimedia.

5 Rheumatology Headlines You Missed in November 2025 Victoria Johnson

This rheumatology month in review emphasizes new data from the ACR Convergence.

Firsekibart Beats Colchicine as Gout Flare Prophylaxis When Initiating ULT Victoria Johnson

New data support firsekibart's efficacy over colchicine for preventing acute gout flares.

Lingdolinurad Demonstrates Dose-Dependent Serum Uric Acid Reductions Victoria Johnson

A new study reveals ligdolinurad effectively lowers uric acid levels in gout patients, showcasing promising safety and tolerability results.

Latest News

Predictors Identified for Super-Responder Status to Dupilumab in Atopic Dermatitis

12 Months of Low-Level Laser Therapy at Home Improves Androgenetic Alopecia

BEACON: Positive Results Announced for Briquilimab in Chronic Spontaneous Urticaria

Family Quality of Life Burden in CSU Increased by Lack of Disease Control

Upadacitinib Superior to 4 Other JAKi Monotherapies for Atopic Dermatitis

Q4 2025 Recap: Dermatology News and Updates

News All Time

The HCPFive: Top News for Healthcare Providers from the Week of 12/14

The HCPFive: Top News for Healthcare Providers from the Week of 12/14

BMI, Inflammatory Bowel Disease Both Show Causal Effect on HS Development

BMI, Inflammatory Bowel Disease Both Show Causal Effect on HS Development

Nemolizumab Rapidly Relieves Itch in Atopic Dermatitis, Prurigo Nodularis

Nemolizumab Rapidly Relieves Itch in Atopic Dermatitis, Prurigo Nodularis

Phase 3 SCALP Study on Clascoterone for Androgenetic Alopecia, With Maria Hordinsky, MD

Phase 3 SCALP Study on Clascoterone for Androgenetic Alopecia, With Maria Hordinsky, MD

Vixarelimab Demonstrates Rapid, Sustained Clinical Benefits in Prurigo Nodularis

Vixarelimab Demonstrates Rapid, Sustained Clinical Benefits in Prurigo Nodularis

Once-Daily Oral Zasocitinib Delivers Strong Phase 3 Efficacy in Plaque Psoriasis

Once-Daily Oral Zasocitinib Delivers Strong Phase 3 Efficacy in Plaque Psoriasis

REZOLVE-AA: Phase 2b Data Released on Rezpegaldesleukin for Alopecia Areata

REZOLVE-AA: Phase 2b Data Released on Rezpegaldesleukin for Alopecia Areata

Special Report: Reframing Skin Pain in Atopic Dermatitis Mona Shahriari, MD, FAAD, Andrew Mastro, MS, PA-C

This video explores skin pain as a key symptom of atopic dermatitis and reviews clinical trial data with JAK inhibitors.

Skin of Color Savvy: Winter Skin Care for Patients of Color, With Heather Woolery-Lloyd, MD, and Aderonke Obayomi, MD, MPH

Skin of Color Savvy: Winter Skin Care for Patients of Color, With Heather Woolery-Lloyd, MD, and Aderonke Obayomi, MD, MPH

Addictive Behaviors Linked with Chronic Skin Diseases Such as HS, Psoriasis

Addictive Behaviors Linked with Chronic Skin Diseases Such as HS, Psoriasis

Prurigo Nodularis Linked to Increased Risk of Malignancy, Especially Skin Cancers

Prurigo Nodularis Linked to Increased Risk of Malignancy, Especially Skin Cancers

Imsidolimab’s Biologics License Application for Treatment of GPP Submitted to FDA

Imsidolimab’s Biologics License Application for Treatment of GPP Submitted to FDA

Dupilumab Shows Greatest Rate of 2-Year Drug Survival Among Atopic Dermatitis Drugs

Dupilumab Shows Greatest Rate of 2-Year Drug Survival Among Atopic Dermatitis Drugs

Tips on Patient Communication in Dermatology, With Kassandra Holzem, MD Kassandra Holzem, MD

Holzem spoke in this interview about several additional highlights from her session at SDPA Fall regarding red flags in dermatology and when to admit from the clinic.

Key Skin Cancer Terms Not Understood by Almost 1/3 of Patients Surveyed

Key Skin Cancer Terms Not Understood by Almost 1/3 of Patients Surveyed

FDA Proposes Expanding Active Ingredient List for Sunscreens

FDA Proposes Expanding Active Ingredient List for Sunscreens

Recommended News For You

Three out of ten breast cancers detected between screenings, study finds

Having dense breasts is linked to cancer, but advice about breast density can depend on where you live

The lack of psychiatrists may be addressed by community workers.

Immunotherapy in Head and Neck Cancer After Failure of Definitive Therapy.

A study suggests that screening for liver cancer is beneficial for patients with cirrhosis.

Telisotuzumab vedotin shows durable response in some Asian patients with nonsquamous NSCLC

Liquid Biopsy for Colorectal Cancer Screening Might Not Be Ready for Prime Time.

Recommended Articles For You

The Crucial Role of Antithrombin 3 in Preventing Blood Clots: A Comprehensive Guide 

The Capmist DM: A Revolutionary Way to Combat Dry Mouth 

Managing High Potassium Levels: A Comprehensive Guide to Veltassa  

Potential of Device-Assisted Therapy in Non-Muscle-Invasive Bladder Cancer 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Approval in Endometrial Cancer Expanded; Masks at Cancer Centers; NPR Reporter Dies

2.

Nanoparticle vaccine prevents multiple cancers and stops metastasis in mice

3.

Many women undergo annual mammography, despite biennial screening recommendations

4.

High-speed whole-body SPECT tracks tumor evolution to optimize prostate cancer treatment

5.

Mammo Responsibility Increases Screening; Opioids for Pain Related to Cancer? Ignored CRC Signs.

1.

Uncovering Breast Cancer: The Power of Early Stage Ultrasound

2.

Demystifying Lymphocytes: Everything You Need to Know 

3.

Is AI The New Radiologist For Breast MRI?

4.

AI in Genomics: Decoding the Human Genome for Cancer Treatment

5.

Understanding Vaso Occlusive Crisis: Symptoms, Causes, and Management Strategies

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Summarization of the New Perspective

2.

"Lorlatinib Upfront": A Niche but Powerful Option For ALK+ NSCLC

3.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII

4.

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

5.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VII

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot